NASDAQ:FMED Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News $29.56 -0.54 (-1.79%) As of 07/10/2026 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock About Fidelity Disruptive Medicine ETF (NASDAQ:FMED) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FMED alerts:Sign Up Key Stats Today's Range$29.36▼$30.3350-Day Range$23.91▼$30.0852-Week Range$22.80▼$30.33Volume9,105 shsAverage Volume12,366 shsMarket Capitalization$47.30 millionAssets Under Management$47.92 millionDividend YieldN/ANet Expense Ratio0.51%Aggregate RatingModerate Buy ETF Overview The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity. Read More Fidelity Disruptive Medicine ETF ExpensesTypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.57%0.54%0.53%Other Expenses0.01%0.58%0.55%0.51%0.55%Total Expense0.51%0.74%0.76%0.73%0.73%Fee Waiver0.00%-0.75%-0.64%-0.50%-0.62%Net Expense0.51%0.60%0.63%0.62%0.60% Receive FMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FMED ETF News HeadlinesFidelity Disruptive Medicine ETFJuly 2, 2026 | markets.businessinsider.comFidelity Covington Trust - Fidelity Disruptive Medicine ETFMay 15, 2026 | money.usnews.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.July 12 at 1:00 AM | Porter & Company (Ad)Fidelity Disruptive Medicine ETF declares $0.112 dividendDecember 22, 2024 | seekingalpha.comSee More Headlines FMED ETF - Frequently Asked Questions How have FMED shares performed this year? Fidelity Disruptive Medicine ETF's stock was trading at $27.05 at the start of the year. Since then, FMED shares have increased by 9.3% and is now trading at $29.56. How do I buy shares of Fidelity Disruptive Medicine ETF? Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerFidelity Fund NameFidelity Disruptive Medicine ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FMED Inception Date6/12/2023 Fund ManagerNiamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings80 Fund Statistics Assets Under Management$47.92 million Average Daily Volume$0.00 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorFidelity Management & Research Company, LLC AdvisorFidelity Management & Research Company, LLC CustodianState Street Bank and Trust Company DistributorFidelity Distributors Company LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Miscellaneous Outstanding Shares1,600,000Beta0.74 Creation Fee$200.00 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report Top 10 FMED HoldingsFidelity Securities Lending Cash Central FundHolding Weight: 9.14%LifeStance Health Group (NASDAQ:LFST)Holding Weight: 4.00%Danaher (NYSE:DHR)Holding Weight: 3.72%10x Genomics (NASDAQ:TXG)Holding Weight: 3.60%argenex (NASDAQ:ARGX)Holding Weight: 3.14%Thermo Fisher Scientific (NYSE:TMO)Holding Weight: 3.06%UCB SAHolding Weight: 3.03%Moderna (NASDAQ:MRNA)Holding Weight: 2.80%Cogent Biosciences (NASDAQ:COGT)Holding Weight: 2.75%Intuitive Surgical (NASDAQ:ISRG)Holding Weight: 2.51%Full Holdings DetailsFMED Sector ExposureFMED Industry Exposure This page (NASDAQ:FMED) was last updated on 7/12/2026 by MarketBeat.com Staff. From Our PartnersWhen governments buy their own debt, gold miners moveOn April 16th, the U.S. Treasury executed a $15 billion buyback of its own debt - the largest in history - whi...Golden Portfolio | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredThey proved it worked in '76. Then buried it.In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredSpaceX Opens Up 11% — Here’s What You Need to KnowSpaceX - ticker SPCX - just completed the biggest IPO in American history, raising $75 billion at a $1.8 trill...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
